586 related articles for article (PubMed ID: 33734592)
1. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea.
Deng Z; Chen M; Liu Y; Xu S; Ouyang Y; Shi W; Jian D; Wang B; Liu F; Li J; Shi Q; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Zhang H; Wang Q; Sun L; Xie H; Li J
EMBO Mol Med; 2021 May; 13(5):e13560. PubMed ID: 33734592
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-κB activation in keratinocytes.
Chen M; Xie H; Chen Z; Xu S; Wang B; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Li J; Deng Z
Biomed Pharmacother; 2019 Aug; 116():109011. PubMed ID: 31132668
[TBL] [Abstract][Full Text] [Related]
3. TLR7 promotes skin inflammation via activating NFκB-mTORC1 axis in rosacea.
Huang Y; Liu D; Chen M; Xu S; Peng Q; Zhu Y; Long J; Liu T; Deng Z; Xie H; Li J; Liu F; Xiao W
PeerJ; 2023; 11():e15976. PubMed ID: 37780385
[TBL] [Abstract][Full Text] [Related]
4. A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.
Zhang J; Jiang P; Sheng L; Liu Y; Liu Y; Li M; Tao M; Hu L; Wang X; Yang Y; Xu Y; Liu W
Front Immunol; 2021; 12():609615. PubMed ID: 34322115
[TBL] [Abstract][Full Text] [Related]
5. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea.
Yamasaki K; Di Nardo A; Bardan A; Murakami M; Ohtake T; Coda A; Dorschner RA; Bonnart C; Descargues P; Hovnanian A; Morhenn VB; Gallo RL
Nat Med; 2007 Aug; 13(8):975-80. PubMed ID: 17676051
[TBL] [Abstract][Full Text] [Related]
6. mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea.
Peng Q; Sha K; Liu Y; Chen M; Xu S; Xie H; Deng Z; Li J
Front Cell Dev Biol; 2021; 9():751785. PubMed ID: 34993194
[TBL] [Abstract][Full Text] [Related]
7. Aspirin alleviates skin inflammation and angiogenesis in rosacea.
Deng Z; Xu S; Peng Q; Sha K; Xiao W; Liu T; Zhang Y; Wang B; Xie H; Chen M; Li J
Int Immunopharmacol; 2021 Jun; 95():107558. PubMed ID: 33743316
[TBL] [Abstract][Full Text] [Related]
8. Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway.
Yuan X; Sheng L; Shi G; Jiang L; Lian C
Inflammation; 2024 Jun; 47(3):1002-1014. PubMed ID: 38279067
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of cathelicidin by direct activation of protease-activated receptor 2: possible implications on the pathogenesis of rosacea.
Kim JY; Kim YJ; Lim BJ; Sohn HJ; Shin D; Oh SH
Yonsei Med J; 2014 Nov; 55(6):1648-55. PubMed ID: 25323904
[TBL] [Abstract][Full Text] [Related]
10. Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2‒NF-κB Signaling.
Li G; Tang X; Zhang S; Deng Z; Wang B; Shi W; Xie H; Liu B; Li J
J Invest Dermatol; 2022 Oct; 142(10):2580-2590.e6. PubMed ID: 35413292
[TBL] [Abstract][Full Text] [Related]
11. Celastrol inhibits LL37-induced rosacea by inhibiting Ca
Zeng Q; Yang J; Yan G; Zhang L; Wang P; Zhang H; Chen Q; Cao Y; Liu X; Wang X
Biomed Pharmacother; 2022 Sep; 153():113292. PubMed ID: 35717785
[TBL] [Abstract][Full Text] [Related]
12. Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea.
Muto Y; Wang Z; Vanderberghe M; Two A; Gallo RL; Di Nardo A
J Invest Dermatol; 2014 Nov; 134(11):2728-2736. PubMed ID: 24844861
[TBL] [Abstract][Full Text] [Related]
13.
Roh KB; Ryu DH; Cho E; Weon JB; Park D; Kweon DH; Jung E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33256158
[TBL] [Abstract][Full Text] [Related]
14. [New insights in the pathogenesis and treatment of rosacea].
Palatsi R; Kelhälä HL; Hägg P
Duodecim; 2012; 128(22):2327-35. PubMed ID: 23342479
[TBL] [Abstract][Full Text] [Related]
15. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin.
Lee JB; Bae SH; Moon KR; Na EY; Yun SJ; Lee SC
Exp Dermatol; 2016 Dec; 25(12):956-961. PubMed ID: 27315464
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.
Coda AB; Hata T; Miller J; Audish D; Kotol P; Two A; Shafiq F; Yamasaki K; Harper JC; Del Rosso JQ; Gallo RL
J Am Acad Dermatol; 2013 Oct; 69(4):570-7. PubMed ID: 23871720
[TBL] [Abstract][Full Text] [Related]
17. Targeting Aquaporin-3 Attenuates Skin Inflammation in Rosacea.
Chen M; Peng Q; Tan Z; Xu S; Wang Y; Wu A; Xiao W; Wang Q; Xie H; Li J; Shi W; Deng Z
Int J Biol Sci; 2023; 19(16):5160-5173. PubMed ID: 37928265
[TBL] [Abstract][Full Text] [Related]
18. Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway.
Shen S; Yan G; Cao Y; Zeng Q; Zhao J; Wang X; Wang P
Biomed Pharmacother; 2023 Jan; 157():114091. PubMed ID: 36481403
[TBL] [Abstract][Full Text] [Related]
19. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes.
Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S
J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315
[TBL] [Abstract][Full Text] [Related]
20. Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea.
Zhang J; Xu X; Rao NV; Argyle B; McCoard L; Rusho WJ; Kennedy TP; Prestwich GD; Krueger G
PLoS One; 2011 Feb; 6(2):e16658. PubMed ID: 21347371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
